Zinc Finger Proteins Modulate Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for obtaining and differentiating stem cells are inefficient, expensive, and lack control over cell fate, making it difficult to obtain transplantable cells for damaged or diseased tissues, particularly for CNS, PNS, or other tissues.
Innovation Solution
The use of engineered zinc finger proteins (ZFPs) to alter the state of differentiation in stem cells, allowing for dedifferentiation or differentiation into specific cell types, and to enhance proliferation, by modulating the expression of genes involved in growth and differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods are used to obtain and differentiate stem cells, then stem cells can be obtained, but the process is inefficient and expensive with little control over cell fate
Solution Approach 1:
The patent applies parameter changes by modifying the chemical environment through the addition of specific growth factors (VEGF, FGF, EGF, IGF, TGF, PDGF, NGF, Bcl-2) to control stem cell differentiation. By systematically varying these biochemical parameters, the invention achieves precise control over cell fate while improving differentiation efficiency and reducing costs compared to conventional methods.
2Reliability
If existing protocols for stem cell growth are used, then stem cells can be maintained, but they depend on feeder cells which create risks of infection, cell fusion and contamination
Solution Approach 1:
The patent extracts and eliminates the feeder cell layer from the stem cell culture system. By removing this source of contamination and complexity, the invention maintains stem cell purity and reliability while simplifying the culture system. The stem cells are grown in defined media without requiring external feeder cells, thereby eliminating risks of infection, cell fusion, and contamination.
3Adaptability or versatility
If embryonic or fetal stem cells are used for treatment, then renewable sources of stem cells are available, but ethical considerations mitigate against their use
Solution Approach 1:
The patent inverts the approach by using adult stem cells (which are ethically acceptable) and applying differentiation protocols that normally work in reverse - using growth factors to induce differentiation rather than preventing it. This allows the generation of specific cell types from adult stem cells, providing a renewable, ethically acceptable source that can be adapted for various tissue replacements.
4Quantity of substance
If hematopoietic stem cells are isolated based on cell surface proteins, then stem cells can be obtained, but the yields are very small
Solution Approach 1:
The patent changes the isolation parameter from cell surface protein markers (CD34) to functional characteristics and growth responses. By using growth factor-based protocols and functional assays, the invention dramatically increases stem cell yield while simplifying the isolation process. The methods enable recovery of sufficient cells for multilineage differentiation that was not achievable with conventional protein-based isolation.
Data Source
AI summary
Methods and compositions for modifying stem cells using one or more ZFPs are disclosed. Such methods and compositions are useful for facilitating processes such as, for example, dedifferentiating cells, differentiating stems cells into the desired phenotype, propagating stem cells and/or facilitating cloning.